和元生物(688238)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688238 和元生物

已收盘 12-25 15:00:00

{"stockData":{"symbol":"688238","market":"SH","secType":"STK","nameCN":"和元生物","latestPrice":5.29,"timestamp":1735110000000,"preClose":5.46,"halted":0,"volume":8470855,"delay":0,"floatShares":467000000,"shares":649000000,"eps":-0.38,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.17,"latestTime":"12-25 15:00:00","open":5.56,"high":5.62,"low":5.25,"amount":45293600,"amplitude":0.0678,"askPrice":5.29,"askSize":386,"bidPrice":5.28,"bidSize":501,"shortable":0,"etf":0,"ttmEps":-0.38,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735176600000},"adr":0,"adjPreClose":5.46,"symbolType":"stock_kcb","openAndCloseTimeList":[[1735090200000,1735097400000],[1735102800000,1735110000000]],"highLimit":6.01,"lowLimit":4.91,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":649036700,"pbRate":1.84,"roa":"--","roe":"--","epsLYR":-0.199,"committee":0.23356,"marketValue":3433000000,"floatMarketCap":2469000000,"peRate":-13.921053,"changeRate":-0.0311,"turnoverRate":0.0181,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2024-12-27。","afterMarket":{"amount":0,"volume":0,"close":5.29,"buyVolume":0,"sellVolume":0,"time":1735112038975,"indexStatus":"已收盘 12-25 15:30:00","preClose":5.46}},"requestUrl":"/m/hq/s/688238","defaultTab":"news","newsList":[{"id":"2493878151","title":"和元生物跌5% 主力净流入289万","url":"https://stock-news.laohu8.com/highlight/detail?id=2493878151","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493878151?lang=zh_cn&edition=full","pubTime":"2024-12-23 14:41","pubTimestamp":1734936062,"startTime":"0","endTime":"0","summary":"12月23日，和元生物股价大幅下跌，截至14点41分，和元生物下跌5.10%，报5.40元/股，成交4307万元，换手率1.67%。资金动向截止发稿，和元生物获得主力净流入289万元，其中超大单流入163万元，大单流入126万元。数据显示，该股今日净流入较近5日净流入均值增加486万元。最新财报显示，今年三季报，和元生物实现营业收入1.84亿元，同比增长34.22%，净利润为-1.90亿元，同比减少166.90%，基本每股收益为-0.29元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122314411195ead162&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024122314411195ead162&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2493276524","title":"【机构调研记录】华泰柏瑞基金调研和元生物、汤姆猫","url":"https://stock-news.laohu8.com/highlight/detail?id=2493276524","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493276524?lang=zh_cn&edition=full","pubTime":"2024-12-23 08:01","pubTimestamp":1734912094,"startTime":"0","endTime":"0","summary":"华泰柏瑞基金成立于2004年，截至目前，资产管理规模6822.87亿元，排名15/208；资产管理规模2979.55亿元，排名19/208；管理公募基金数284只，排名22/208；旗下公募基金经理40人，排名28/208。旗下最近一年表现最佳的公募基金产品为华泰柏瑞新金融地产混合C，最新单位净值为1.55，近一年增长41.9%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122300001265.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0217","688238","300459","BK0094","BK0216","BK0077"],"gpt_icon":0},{"id":"2492419479","title":"和元生物：12月5日接受机构调研，东吴证券、嘉实基金等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2492419479","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492419479?lang=zh_cn&edition=full","pubTime":"2024-12-20 19:32","pubTimestamp":1734694369,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年12月20日和元生物发布公告称公司于2024年12月5日接受机构调研，东吴证券、嘉实基金、光大证券、国君资管、华泰柏瑞基金、湘禾资产参与。2024 年前三季度，细胞基因治疗 CRO 业务收入 6,030.45万元，较上年同期增长 13.78%；截至报告期末，客户群体不断扩大，累计服务超过 12,000 家研发实验室客户。2024 年上半年，公司各项资产折旧摊销费用为4497.99 万元，其中主要因临港产业基地逐步投入使用，导致固定资产折旧与摊销持续增长。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122000037025.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601555","BK0216","BK0012","BK0183","688238","BK0188","BK0028","BK0276","BK0009"],"gpt_icon":0},{"id":"2492412192","title":"和元生物：2024年前三季度CDMO订单超过2.5亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492412192","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492412192?lang=zh_cn&edition=full","pubTime":"2024-12-20 18:11","pubTimestamp":1734689479,"startTime":"0","endTime":"0","summary":"金融界12月20日消息，和元生物披露投资者关系活动记录表显示，公司临港产业基地建设规划于2020年，为解决公司面临的GMP产能瓶颈问题。目前GMP产能利用率正在持续提升中。公司深耕细胞与基因治疗CRO/CDMO领域，2024年前三季度新增的CDMO订单超过2.5亿元。细胞和基因治疗CRO业务方面，公司积极拓展服务场景，以适应市场需求，保持业绩稳定增长。公司于2024年投资设立全资子公司和元和美，专注于解决细胞安全、可追溯方面的难题，实现细胞规模化生产，未来有望发展成为公司业绩增长的新亮点。公司表示，将继续发挥细胞基因治疗CRO/CDMO的重要专业作用，持续赋能细胞和基因治疗领域发展。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220202327a1fdd086&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220202327a1fdd086&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2492964465","title":"和元生物跌5% 1券商建议买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2492964465","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492964465?lang=zh_cn&edition=full","pubTime":"2024-12-17 13:15","pubTimestamp":1734412511,"startTime":"0","endTime":"0","summary":"12月17日，和元生物股价大幅下跌，截至13点15分，和元生物下跌5.16%，报5.51元/股，成交3922万元，换手率1.49%。资金动向截止发稿，和元生物获得主力净流出298万元，其中超大单流出162万元，大单流出134万元。融资融券方面，和元生物12月13日获得融资净买入170万元，当日该股融资余额为1.48亿元，当较前一日增加1.16%，实现3连增。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217131519a1f4e319&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217131519a1f4e319&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2490864834","title":"和元生物大涨 近半年获买入建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2490864834","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490864834?lang=zh_cn&edition=full","pubTime":"2024-12-11 09:36","pubTimestamp":1733880987,"startTime":"0","endTime":"0","summary":"12月11日，和元生物股价大幅上涨，截至09点36分，和元生物上涨5.07%，报6.22元/股，成交2422万元，换手率0.85%，振幅3.55%。此外，数据统计显示，近半年内1家券商给予买入建议。资金动向截止发稿，和元生物获得主力净流入121万元，其中超大单流出285万元，大单流入406万元。融资融券方面，和元生物12月09日获得融资净买入400万元，当日该股融资余额为1.46亿元，当较前一日增加2.82%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211093635ab6e2051&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211093635ab6e2051&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2490679797","title":"和元生物大涨 国家口腔联盟组建","url":"https://stock-news.laohu8.com/highlight/detail?id=2490679797","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490679797?lang=zh_cn&edition=full","pubTime":"2024-12-09 09:30","pubTimestamp":1733707818,"startTime":"0","endTime":"0","summary":"12月09日，和元生物股价大幅上涨，截至09点30分，和元生物上涨5.14%，报6.14元/股，成交507万元，换手率0.18%。消息解读国家口腔医学中心组建 12 个专科联盟助力口腔医疗服务。资金动向截止发稿，和元生物获得主力净流入113万元。最新财报显示，今年三季报，和元生物实现营业收入1.84亿元，同比增长34.22%，净利润为-1.90亿元，同比减少166.90%，基本每股收益为-0.29元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209093249a1df03ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209093249a1df03ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2489473606","title":"和元生物上涨5% 获融资净买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2489473606","media":"智选洞察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489473606?lang=zh_cn&edition=full","pubTime":"2024-12-06 13:17","pubTimestamp":1733462227,"startTime":"0","endTime":"0","summary":"12月06日，和元生物股价大幅上涨，截至13点17分，和元生物上涨5.04%，报5.84元/股，成交6707万元，换手率2.55%。资金动向截止发稿，和元生物获得主力净流出172万元，其中超大单流出59万元，大单流出112万元。融资融券方面，和元生物12月04日获得融资净买入105万元，当日该股融资余额为1.48亿元，当较前一日增加0.72%。最新财报显示，今年三季报，和元生物实现营业收入1.84亿元，同比增长34.22%，净利润为-1.90亿元，同比减少166.90%，基本每股收益为-0.29元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206131719a1d844fa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206131719a1d844fa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2489464726","title":"和元生物12月05日遭主力抛售681万元 环比增加113.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489464726","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489464726?lang=zh_cn&edition=full","pubTime":"2024-12-05 15:21","pubTimestamp":1733383285,"startTime":"0","endTime":"0","summary":"12月05日, 和元生物股价涨1.83%，报收5.56元，成交金额4572万元，换手率1.77%，振幅2.93%，量比0.62。和元生物今日主力资金净流出681万元，连续6日净流出，上一交易日主力净流出319万元，今日环比增加113.48%。该股近5个交易日上涨1.46%，主力资金累计净流出3753万元；近20日主力资金累计净流出8306万元，其中净流出天数为16日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205154110ab5f1f59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205154110ab5f1f59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2486519923","title":"和元生物多股东拟减持逾2000万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2486519923","media":"新京报","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486519923?lang=zh_cn&edition=full","pubTime":"2024-11-28 13:22","pubTimestamp":1732771320,"startTime":"0","endTime":"0","summary":"11月28日，和元生物发布公告，股东上海檀英及其一致行动人、东华睿盛银及其一致行动人拟减持公司股份，合计超过2000万股。根据公告，和元生物股东上海檀英及其一致行动人拟通过集中竞价、大宗交易的方式减持所持公司股份合计不超过约1424.35万股，占公司总股本比例不超过2.2%。上述减持自公告披露之日起15个交易日后的3个月内进行。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128132556a25b83d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128132556a25b83d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2486133496","title":"不超过3.2%！和元生物遭多股东拟减持，前三季度净利亏损1.90亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486133496","media":"读创客户端","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486133496?lang=zh_cn&edition=full","pubTime":"2024-11-28 10:09","pubTimestamp":1732759777,"startTime":"0","endTime":"0","summary":"华睿盛银及其一致行动人因股东资金需求，拟减持合计不超过647.43万股，占比1%。减持期间均为2024年12月19日至2025年3月18日。华睿盛银及其一致行动人于2023年4月至10月减持了0.9367%股份，减持总金额为5910.83万元。财务方面，和元生物2023年转亏1.28亿元后，在2024年前三季度延续亏损态势。和2022年的高位相比，和元生物两年多的时间股价已跌超75%，目前跌破发行价超四成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128102841a25b3654&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128102841a25b3654&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2486638723","title":"和元生物股东计划减持最多2071万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2486638723","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486638723?lang=zh_cn&edition=full","pubTime":"2024-11-28 08:29","pubTimestamp":1732753740,"startTime":"0","endTime":"0","summary":"公告显示，股东上海檀英及其一致行动人拟通过集中竞价和大宗交易的方式减持最多1424万股，占公司总股本的2.2%。此外，股东华睿盛银及其一致行动人也计划减持不超过647万股，占总股本的1%。减持计划自公告披露之日起15个交易日后的3个月内进行。截至公告披露日，上海檀英持有公司股份3075万股，占总股本的4.7498%；华睿盛银持有1967万股，占总股本的3.0385%。此次减持主要是由于股东资金需求及基金存续期即将到期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128083400a25af176&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241128083400a25af176&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2486386789","title":"和元生物(688238.SH)部分股东拟合计减持不超3.2%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2486386789","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486386789?lang=zh_cn&edition=full","pubTime":"2024-11-28 06:57","pubTimestamp":1732748232,"startTime":"0","endTime":"0","summary":"智通财经APP讯，和元生物(688238.SH)发布公告，公司股东上海檀英及其一致行动人拟通过集中竞价、大宗交易的方式减持所持公司股份，减持股份数量合计不超过1424.35万股，占公司总股本比例不超过2.2%。公司股东华睿盛银及其一致行动人拟通过集中竞价、大宗交易的方式减持所持公司股份，减持股份数量合计不超过647.43万股，占公司总股本比例不超过1%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1216967.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2486287645","title":"和元生物最新公告：股东拟合计减持不超过3.2%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2486287645","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486287645?lang=zh_cn&edition=full","pubTime":"2024-11-27 23:40","pubTimestamp":1732722016,"startTime":"0","endTime":"0","summary":"和元生物公告，公司股东上海檀英及其一致行动人拟通过集中竞价、大宗交易的方式减持所持公司股份，减持数量合计不超过1424.35万股，占公司总股本比例不超过2.2%。公司股东华睿盛银及其一致行动人拟通过集中竞价、大宗交易的方式减持所持公司股份，减持数量合计不超过647.43万股，占公司总股本比例不超过1%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112700038456.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2486784985","title":"和元生物11月27日现1笔大宗交易 成交金额1729万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486784985","media":"新浪证券-红岸工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486784985?lang=zh_cn&edition=full","pubTime":"2024-11-27 17:40","pubTimestamp":1732700400,"startTime":"0","endTime":"0","summary":"　　11月27日，和元生物收涨0.70%，收盘价为5.73元，发生1笔大宗交易，合计成交量380万股，成交金额1729万元。　　第1笔成交价格为4.55元，成交380.00万股，成交金额1,729.00万元，溢价率为-20.59%，买方营业部为国联证券股份有限公司慈溪影清路证券营业部，卖方营业部为东北证券股份有限公司宁波分公司。　　进一步统计，近3个月内该股累计发生1笔大宗交易，合计成交金额为1729万元。该股近5个交易日累计下跌1.88%，主力资金合计净流入8.73万元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2024-11-27/doc-incxpark3470997.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2486947843","title":"11月27日和元生物现1笔折价20.59%的大宗交易 合计成交1729万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486947843","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486947843?lang=zh_cn&edition=full","pubTime":"2024-11-27 17:20","pubTimestamp":1732699247,"startTime":"0","endTime":"0","summary":"证券之星消息，11月27日和元生物发生大宗交易，交易数据如下：大宗交易成交价格4.55元，相对当日收盘价折价20.59%，成交380万股，成交金额1729万元，买方营业部为国联证券股份有限公司慈溪影清路证券营业部，卖方营业部为东北证券股份有限公司宁波分公司。近三个月该股共发生1笔大宗交易，合计成交3.8万手，折价成交1笔。截至2024年11月27日收盘，和元生物报收于5.73元，上涨0.7%，换手率2.4%，成交量11.18万手，成交额6227.18万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112700028965.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688238","BK0216"],"gpt_icon":0},{"id":"2486777071","title":"和元生物：公司未参加2024中国医药工业和生物医药产业周大会","url":"https://stock-news.laohu8.com/highlight/detail?id=2486777071","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486777071?lang=zh_cn&edition=full","pubTime":"2024-11-25 16:09","pubTimestamp":1732522166,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：请问董秘，2024中国医药工业和生物医药产业周大会在上海召开，公司是否参会，是否在会场签有订单？谢谢。和元生物（688238.SH）11月25日在投资者互动平台表示，公司未参加2024中国医药工业和生物医药产业周大会，公司将根据自身业务规划关注并选择性参与相关行业展会，关于新签订单信息，您可以关注公司定期报告中相关内容。文章来源：每日经济新闻原标题：和元生物：公司未参加2024中国医药工业和生物医药产业周大会","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125163920a253db4e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125163920a253db4e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0250","BK0082","688238","BK0175","161726","BK0010","BK0216","BK0185","BK0028","399441","600056","BK0188"],"gpt_icon":0},{"id":"2483187004","title":"和元生物：11月13日召开业绩说明会，投资者参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2483187004","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483187004?lang=zh_cn&edition=full","pubTime":"2024-11-13 20:34","pubTimestamp":1731501281,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年11月13日和元生物发布公告称公司于2024年11月13日召开业绩说明会。和元生物2024年三季报显示，公司主营收入1.84亿元，同比上升34.22%；归母净利润-1.9亿元，同比下降166.9%；扣非净利润-2.0亿元，同比下降155.03%；其中2024年第三季度，公司单季度主营收入7080.58万元，同比上升32.99%；单季度归母净利润-7642.14万元，同比下降190.56%；单季度扣非净利润-8094.48万元，同比下降156.81%；负债率20.62%，投资收益-130.17万元，财务费用27.9万元，毛利率-21.95%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111300034440.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2482726042","title":"和元生物11月12日遭主力抛售1927万元 环比增加9535.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482726042","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482726042?lang=zh_cn&edition=full","pubTime":"2024-11-12 15:21","pubTimestamp":1731396079,"startTime":"0","endTime":"0","summary":"11月12日, 和元生物股价跌2.13%，报收6.43元，成交金额1.76亿元，换手率5.70%，振幅6.70%，量比1.22。和元生物今日主力资金净流出1927万元，上一交易日主力净流出20万元，今日环比增加9535.00%。该股近5个交易日上涨10.86%，主力资金累计净流出2553万元；近20日主力资金累计净流出2644万元，其中净流出天数为10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112154910a22f8754&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112154910a22f8754&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688238"],"gpt_icon":0},{"id":"2482735243","title":"和元生物创6个月新高 1家券商给予增持建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2482735243","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482735243?lang=zh_cn&edition=full","pubTime":"2024-11-11 09:40","pubTimestamp":1731289257,"startTime":"0","endTime":"0","summary":"11月11日，和元生物股价大幅上涨，截至09点40分，和元生物上涨5.62%，报6.58元/股，创近6个月新高，成交3054万元，换手率1.03%，振幅6.26%。此外，数据统计显示，近半年内1家券商给予增持建议，1家券商给予买入建议。资金动向截止发稿，和元生物获得主力净流出11万元，其中超大单流入18万元，大单流出28万元。最新财报显示，今年三季报，和元生物实现营业收入1.84亿元，同比增长34.22%，净利润为-1.90亿元，同比减少166.90%，基本每股收益为-0.29元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111100834abb455fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111100834abb455fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688238","BK0216"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2022-03-22","address":"上海市浦东新区国际医学园区紫萍路908弄19号楼","stockEarnings":[{"period":"1week","weight":-0.0144},{"period":"1month","weight":-0.0036},{"period":"3month","weight":0.3},{"period":"6month","weight":0.1495},{"period":"1year","weight":-0.3788},{"period":"ytd","weight":-0.3927}],"companyName":"和元生物技术(上海)股份有限公司","boardCode":"AI0073","perCapita":"37393股","boardName":"研究和试验发展","registeredCapital":"64903万元","compareEarnings":[{"period":"1week","weight":0.0095},{"period":"1month","weight":0.0387},{"period":"3month","weight":0.1717},{"period":"6month","weight":0.152},{"period":"1year","weight":0.1626},{"period":"ytd","weight":0.1407}],"survey":"　　和元生物技术(上海)股份有限公司是一家聚焦基因治疗领域的生物科技公司，专注于为基因治疗的基础研究提供基因治疗载体研制、基因功能研究等CRO服务，以及为基因药物的研发提供IND-CMC药学研究、临床样品GMP生产等CDMO服务。主要产品有基因治疗CRO、基因治疗CDMO、生物制剂、试剂。","serverTime":1735138327003,"listedPrice":13.23,"stockholders":"12482人(较上一季度增加3.05%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"和元生物(688238)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供和元生物(688238)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"和元生物,688238,和元生物股票,和元生物股票老虎,和元生物股票老虎国际,和元生物行情,和元生物股票行情,和元生物股价,和元生物股市,和元生物股票价格,和元生物股票交易,和元生物股票购买,和元生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"和元生物(688238)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供和元生物(688238)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}